ArticleGeroScience2026

End-of-life pathology in UM-HET3 mice treated with 16 α‑hydroxyestradiol or late‑start canagliflozin.

Jessica M Snyder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.